EXPRS2 · ExpreS2ion Biotech Holding AB
Market Cap
26.72M SEK
Shares
23.75M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Investor day
Close1.1200 SEK
Open1.1200 SEK
Day1.0800–1.1250 SEK
52W close1.0950–21.5000 SEK
Avg vol 30d95K
Last earningsFeb 25, 2027
DataOct 2024–Oct 2026
Raw chart and full-history price indicators begin at the captured split on Oct 30, 2024; bars on opposite sides are not compared.
Technicals
trend & momentum for long-term holders illustrative — not investment advicePrice context
position in its 52-week range
Range low 1.0950 SEK
Now 1.1200 SEK · 0%
Range high 21.5000 SEK
vs 200-day avg -80%
vs 50-day avg -15%
Illustrative technical + ownership context — a signal mix, not investment advice.
Performance
Raw-price comparisons begin at the captured split on Oct 30, 2024; windows that need an earlier baseline remain unavailable.
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| FNSE:EXPRS2 | +0.5% | -17.0% | -61.9% | -5.9% | -93.0% |
Exchange listing
- Market
- FNSE
- Ticker
- EXPRS2
- ISIN
- SE0023261292
- Security
- —
- Trading currency
- SEK
Company
- Website
- https://expres2ionbio.com/
- Investor relations
- https://investor.expres2ionbio.com/presentations/
Other listings of this company
No other verified listings are available.
Recent dividends
No verified dividend payments are available for this listing yet.
Upcoming investor events
| Date | Event | Type |
|---|---|---|
| 2026-11-12 00:00 UTC | 2026 Interim Report (Q3) | Results publication |
| 2026-12-11 00:00 UTC | 2026 Interim Report (Q3) | Results publication |
| 2027-02-25 00:00 UTC | 2026 Full-Year Report (Q4) | Results publication |
| 2027-05-06 00:00 UTC | 2026 Annual Report | Event |
| 2027-06-05 00:00 UTC | 2026 Annual Report | Event |
Earnings calls
-
Earnings call · Q4 2026 2027-02-25 Scheduled2026 Full-Year Report (Q4)
-
Earnings call · Q3 2026 2026-11-12 Scheduled2026 Interim Report (Q3)